Canada markets open in 3 hours 44 minutes

Medexus Pharmaceuticals Inc. (MDP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.6200+0.0200 (+1.25%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 39.62M
Enterprise Value 99.67M
Trailing P/E 4.10
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.22
Price/Book (mrq)0.98
Enterprise Value/Revenue 0.63
Enterprise Value/EBITDA 3.71

Trading Information

Stock Price History

Beta (5Y Monthly) 1.82
52-Week Change 330.65%
S&P500 52-Week Change 329.31%
52 Week High 33.5300
52 Week Low 31.1200
50-Day Moving Average 31.6406
200-Day Moving Average 32.1765

Share Statistics

Avg Vol (3 month) 343.03k
Avg Vol (10 day) 335.79k
Shares Outstanding 524.46M
Implied Shares Outstanding 624.46M
Float 822.13M
% Held by Insiders 18.69%
% Held by Institutions 18.39%
Shares Short (Apr 30, 2024) 4120.98k
Short Ratio (Apr 30, 2024) 42.27
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.49%
Shares Short (prior month Mar 28, 2024) 480.35k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 19, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Dec 19, 2018

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 5.08%
Operating Margin (ttm)6.22%

Management Effectiveness

Return on Assets (ttm)5.21%
Return on Equity (ttm)26.14%

Income Statement

Revenue (ttm)115.72M
Revenue Per Share (ttm)5.46
Quarterly Revenue Growth (yoy)-12.30%
Gross Profit (ttm)N/A
EBITDA 18.32M
Net Income Avi to Common (ttm)5.88M
Diluted EPS (ttm)0.3900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.21M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)52.29M
Total Debt/Equity (mrq)176.88%
Current Ratio (mrq)1.11
Book Value Per Share (mrq)1.21

Cash Flow Statement

Operating Cash Flow (ttm)20.97M
Levered Free Cash Flow (ttm)8.24M